ICH Quality Guidelines Q1–Q14
A structured master hub covering the International Council for Harmonisation (ICH) Quality guideline family—from stability and impurities to pharmaceutical development, quality risk management, lifecycle management, continuous manufacturing, and analytical procedure development.
What are ICH Quality Guidelines?
ICH Quality Guidelines harmonise key technical expectations for pharmaceutical quality across major regulatory systems. They address how drug substances and drug products are developed, tested, manufactured, controlled, evaluated and managed throughout their lifecycle.
Q1StabilityStability study design, photostability, bracketing/matrixing and data evaluation+
Q2Analytical ValidationValidation principles for analytical procedures+
Q3ImpuritiesOrganic impurities, residual solvents, elemental impurities, extractables and leachables+
Q4PharmacopoeiasPharmacopoeial harmonisation and evaluation of general test chapters+
Q5Quality of Biotechnological ProductsViral safety, expression constructs, cell substrates, stability and comparability+
Q6SpecificationsTest procedures and acceptance criteria for chemical and biological products+
Q7Good Manufacturing PracticeGMP for active pharmaceutical ingredients+
Q8Pharmaceutical DevelopmentScience- and risk-based pharmaceutical development and design space concepts+
Q9Quality Risk ManagementPrinciples and tools for science- and risk-based quality decisions+
Q10Pharmaceutical Quality SystemLifecycle pharmaceutical quality management model+
Q11Development and Manufacture of Drug SubstancesDrug-substance process development, control strategy and starting materials+
Q12Lifecycle ManagementTechnical and regulatory management of post-approval product changes+
Q13Continuous ManufacturingDevelopment, implementation, operation and lifecycle management of continuous manufacturing+
Q14Analytical Procedure DevelopmentScience- and risk-based development of analytical procedures+
Important current-development items
Several Quality topics are being revised, maintained or expanded. Treat draft/EWG items separately from final harmonised guidelines.
Frequently Asked Questions
What do ICH Quality Guidelines cover?
They cover pharmaceutical quality topics such as stability, analytical validation and development, impurities, pharmacopoeial harmonisation, biotechnology products, specifications, API GMP, pharmaceutical development, quality risk management, pharmaceutical quality systems, drug-substance development, lifecycle management and continuous manufacturing.
Which ICH guideline covers GMP for active pharmaceutical ingredients?
ICH Q7 is the Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, supported by a Q&A document for implementation and interpretation.
Which ICH guidelines cover analytical methods?
ICH Q2(R2) addresses validation of analytical procedures, while ICH Q14 addresses analytical procedure development. ICH also provides combined Q2(R2)/Q14 training materials.
Is ICH Q1F still an active guideline?
No. ICH Q1F was withdrawn. Stability requirements for climatic zones III and IV should be checked against current WHO guidance and applicable regional requirements.
How should this master page be used?
Use it as a navigation and learning hub. Each guideline can later be linked to a dedicated Web of Pharma article, summary, checklist, training page or official ICH reference.
.webp)
